Nanomaterials and their Immunological Perspectives

Allahyari, M., & Mohit, E. Peptide/protein vaccine delivery system based on PLGA particles. Human Vaccines & Immunotherapeutics. 2016 Mar 3;12(3):806–828.

Corbo, C., Molinaro, R., Parodi, A., Toledano Furman, N. E., Salvatore, F., & Tasciotti, E. The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery. Nanomedicine. 2016 Jan;11(1):81–100.

Dolez, P. I. Nanomaterials Definitions, Classifications, and Applications. In Nanoengineering 2015 (pp. 3–40). Elsevier, Amsterdam.

Gaspar, R. S., Silva-Lima, B., Magro, F., Alcobia, A., da Costa, F. L., & Feio, J. Non-biological Complex Drugs (NBCDs): Complex Pharmaceuticals in Need of Individual Robust Clinical Assessment Before Any Therapeutic Equivalence Decision. Frontiers in Medicine. 2020 Nov 23;7:590527.

GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England). 2018 Nov 10;392(10159):1736–1788.

Goldberg, M. S. Immunoengineering: How nanotechnology can enhance cancer immunotherapy. Cell. 2015 Apr 9;161(2):201–204.

Gupta, A. K., & Gupta, M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials. 2005 Jun;26(18):3995–4021.

Hainfeld, J. F., Slatkin, D. N., Focella, T. M., & Smilowitz, H. M. Gold nanoparticles: A new X-ray contrast agent. The British Journal of Radiology. 2006 Mar;79(939):248–253.

Hammond, P. T. Nano Tools Pave the Way to New Solutions in Infectious Disease. ACS Infectious Diseases. 2017 Aug 11;3(8):554–558.

Ji, X., Peng, F., Zhong, Y., Su, Y., & He, Y. Fluorescent quantum dots: Synthesis, biomedical optical imaging, and biosafety assessment. Colloids and Surfaces. B, Biointerfaces. 2014 Dec 1;124:132–139.

Kirtane, A. R., Verma, M., Karandikar, P., Furin, J., Langer, R., & Traverso, G. Nanotechnology approaches for global infectious diseases. Nature Nanotechnology. 2021 Apr;16(4):369–384.

Kranz, L. M., Diken, M., Haas, H., Kreiter, S., Loquai, C., Reuter, K. C., Meng, M., Fritz, D., Vascotto, F., Hefesha, H., Grunwitz, C., Vormehr, M., Hüsemann, Y., Selmi, A., Kuhn, A. N., Buck, J., Derhovanessian, E., Rae, R., Attig, S., Diekmann, J., Jabulowsky, A. R., Heesch. S., Hassel, J., Langguth, P., Grabbe, S., Huber, C., Türeci, Ö., Sahin, U. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature. 2016 Jun 16;534(7607):396–401.

Kyriakides, T. R., Raj, A., Tseng, T. H., Xiao, H., Nguyen, R., Mohammed, F. S., Halder, S., Xu, M., Wu, M. J., Bao, S., & Sheu, W. C. Biocompatibility of nanomaterials and their immunological properties. Biomedical Materials (Bristol, England). 2021 Mar 11;16(4).

Lee, J.-R., Haddon, D. J., Gupta, N., Price, J. V., Credo, G. M., Diep, V. K., Kim, K., Hall, D. A., Baechler, E. C., Petri, M., Varma, M., Utz, P. J., & Wang, S. X. High-Resolution Analysis of Antibodies to Post-Translational Modifications Using Peptide Nanosensor Microarrays. ACS Nano. 2016 Dec 27;10(12):10652–10660.

Lei, C., Liu, P., Chen, B., Mao, Y., Engelmann, H., Shin, Y., Jaffar, J., Hellstrom, I., Liu, J., & Hellstrom, K. E. Local release of highly loaded antibodies from functionalized nanoporous support for cancer immunotherapy. Journal of the American Chemical Society. 2010 May 26;132(20):6906–6907.

Lenders, V., Koutsoumpou, X., Sargsian, A., & Manshian, B. B. Biomedical nanomaterials for immunological applications: Ongoing research and clinical trials. Nanoscale Advances. 2020 Nov 11;2(11):5046–5089.

Mabrouk, M., Das, D. B., Salem, Z. A., & Beherei, H. H. Nanomaterials for Biomedical Applications: Production, Characterisations, Recent Trends and Difficulties. Molecules. 2021 Feb 18;26(4):1077.

Nune, S. K., Gunda, P., Thallapally, P. K., Lin, Y.-Y., Forrest, M. L., & Berkland, C. J. Nanoparticles for biomedical imaging. Expert Opinion on Drug Delivery. 2009 Nov;6(11):1175–1194.

Ray, P., Haideri, N., Haque, I., Mohammed, O., Chakraborty, S., Banerjee, S., Quadir, M., Brinker, A. E., Banerjee, S. K. The Impact of Nanoparticles on the Immune System: A Gray Zone of Nanomedicine. Journal of Immunological Sciences. 2021 Mar 8;5(1):19-33.

Shen, Y., Hao, T., Ou, S., Hu, C., & Chen, L. Applications and perspectives of nanomaterials in novel vaccine development. MedChemComm. 2018 Feb 1;9(2):226–238.

Singh, L., Kruger, H. G., Maguire, G. E. M., Govender, T., & Parboosing, R. The role of nanotechnology in the treatment of viral infections. Therapeutic Advances in Infectious Disease. 2017 Jul;4(4):105–131.

Song, W., Musetti, S. N., & Huang, L. Nanomaterials for Cancer Immunotherapy. Biomaterials. 2017 Dec;148:16–30.

Tomalia, D. A. In quest of a systematic framework for unifying and defining nanoscience. Journal of Nanoparticle Research: An Interdisciplinary Forum for Nanoscale Science and Technology. 2009 Aug;11(6):1251–1310.

Welsher, K., Liu, Z., Daranciang, D., & Dai, H. Selective probing and imaging of cells with single walled carbon nanotubes as near-infrared fluorescent molecules. Nano Letters. 2008 Feb;8(2):586–590.

Xiang, S. D., Selomulya, C., Ho, J., Apostolopoulos, V., & Plebanski, M. Delivery of DNA vaccines: An overview on the use of biodegradable polymeric and magnetic nanoparticles. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 2010 May-Jun;2(3):205–218.

Zolnik, B. S., González-Fernández, Á., Sadrieh, N., & Dobrovolskaia, M. A. Nanoparticles and the Immune System. Endocrinology. 2010 Feb;151(2):458–465.